| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/J.SEMPERI.2005.05.004 |
| P8608 | Fatcat ID | release_o5ihebgv2nfbvgzwgxzni33ija |
| P698 | PubMed publication ID | 16104677 |
| P2093 | author name string | Dave Wright | |
| Peter Benn | |||
| Howard Cuckle | |||
| P433 | issue | 4 | |
| P921 | main subject | meta-analysis | Q815382 |
| Down syndrome | Q47715 | ||
| P304 | page(s) | 252-257 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Seminars in Perinatology | Q15763431 |
| P1476 | title | Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters | |
| P478 | volume | 29 |
| Q33818130 | Analysis of Down syndrome failed to be diagnosed after prenatal screening: A multicenter study |
| Q45912341 | Analysis of secondary ultrasound markers in the first trimester before chorionic villus sampling |
| Q34209281 | Assessment of Foetal DNA in Maternal Blood - A Useful Tool in the Hands of Prenatal Specialists |
| Q92685320 | Association of Low Maternal Pregnancy-associated Plasma Protein A with Adverse Perinatal Outcome |
| Q51042727 | Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies. |
| Q37750847 | Down syndrome screening: imagining the screening test of the future. |
| Q51398944 | Evaluation of population parameters and mathematical strategies for the calculation of prenatal risk of Down syndrome in the first trimester of pregnancy. |
| Q47178004 | Extrapolation of maternal weight in sequential aneuploidy screening |
| Q35667236 | First Trimester Aneuploidy Screening Markers in Women with Pre-Gestational Diabetes Mellitus |
| Q37208068 | First- and second-trimester Down syndrome screening: current strategies and clinical guidelines. |
| Q33886427 | Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening. |
| Q30406201 | Limitations of Aneuploidy and Anomaly Detection in the Obese Patient |
| Q35667145 | Maternal Serum Screening Markers and Adverse Outcome: A New Perspective |
| Q38182095 | Noninvasive prenatal testing: the future is now. |
| Q58029252 | PRENATAL SCREENING AND DIAGNOSIS OF FETAL CHROMOSOMAL ABNORMALITIES – DILEMMA BETWEEN BEST EVIDENCE-BASED MODEL AND PRACTICABILITY |
| Q90728684 | Prenatal Screening Markers for Down Syndrome: Sensitivity, Specificity, Positive and Negative Expected Value Method |
| Q39692651 | Quantitative performance of antibody array technology in a prenatal screening setting |
| Q48586107 | Strong impact of ethnicity on effectiveness of the first trimester maternal serum screen of fetal Down syndrome |
Search more.